Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: A case-control study.

[1]  S. Mathoulin-Pélissier,et al.  The prognostic value of G8 for functional decline. , 2019, Journal of geriatric oncology.

[2]  P. Schofield,et al.  Detection of alcohol abuse in older patients with cancer: The integration of alcohol screening questionnaires in the comprehensive geriatric assessment. , 2019, Journal of geriatric oncology.

[3]  P. Schofield,et al.  The added value of an assessment of the patient's hand grip strength to the comprehensive geriatric assessment in G8-abnormal older patients with cancer in routine practice. , 2019, Journal of geriatric oncology.

[4]  H. Wildiers,et al.  The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer , 2018, Cancer.

[5]  A. Hurria Dosing drugs in elderly patients with cancer. , 2018, Clinical advances in hematology & oncology : H&O.

[6]  M. Fakih,et al.  Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT). , 2018 .

[7]  H. Cohen,et al.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  H. Cohen,et al.  Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602) , 2018, The oncologist.

[9]  P. Schofield,et al.  The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment , 2018, Acta clinica Belgica.

[10]  M. Lycke,et al.  G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy , 2015, BMC Cancer.

[11]  Laura A. Levit,et al.  Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Mathoulin-Pélissier,et al.  Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study , 2014, PloS one.

[13]  H. Wildiers,et al.  Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment , 2014, Psycho-Oncology.

[14]  H. Wildiers,et al.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  H. Cohen,et al.  Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  W. De Neve,et al.  Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life. , 2014, European journal of cancer care.

[17]  Hons Psych PhD Honorary Fellow V.E. Knott B.A.,et al.  Themes for our journal: 2014–2016 , 2014 .

[18]  H. Cohen,et al.  Underrepresentation of older adults in cancer trials--reply. , 2014, JAMA.

[19]  Murielle Mauer,et al.  End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Lycke,et al.  Use of the Freund clock drawing test within the Mini-Cog as a screening tool for cognitive impairment in elderly patients with or without cancer. , 2012, Journal of geriatric oncology.

[21]  B. V. van Munster,et al.  Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. , 2012, The Lancet. Oncology.

[22]  S. Mathoulin-Pélissier,et al.  Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  K. Scher,et al.  Under-representation of older adults in cancer registration trials: known problem, little progress. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Mohile,et al.  Research priorities in geriatric oncology: addressing the needs of an aging population. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[25]  S. Mathoulin-Pélissier,et al.  Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Kattan,et al.  Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology , 2010, BJU international.

[27]  D. Lacombe,et al.  EORTC elderly task force position paper: approach to the older cancer patient. , 2010, European journal of cancer.

[28]  A. Brunello,et al.  Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool. , 2009, Cancer treatment reviews.

[29]  Benjamin D Smith,et al.  Future of cancer incidence in the United States: burdens upon an aging, changing nation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  C. Terret How and why to perform a geriatric assessment in clinical practice. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  G. Zulian,et al.  Multidisciplinary approach to the geriatric oncology patient. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Dignam,et al.  A pilot study of the vulnerable elders survey‐13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation , 2007, Cancer.

[33]  H. Cohen,et al.  Developing a cancer‐specific geriatric assessment , 2005, Cancer.

[34]  H. Cohen,et al.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). , 2005, Critical reviews in oncology/hematology.

[35]  Barbara Freund,et al.  Drawing clocks and driving cars , 2005, Journal of General Internal Medicine.

[36]  H. Cohen,et al.  Never too old? Age should not be a barrier to enrollment in cancer clinical trials. , 2005, The oncologist.

[37]  L. Siu,et al.  Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Joy H. Lewis,et al.  Participation of patients 65 years of age or older in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  M. Extermann Comprehensive geriatric assessment basics for the cancer professional. , 2003, The Journal of oncology management : the official journal of the American College of Oncology Administrators.

[40]  Elizabeth H Bradley,et al.  Understanding the treatment preferences of seriously ill patients. , 2002, The New England journal of medicine.

[41]  W. Gianni,et al.  Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Serraino,et al.  Prevalence of functional disability among elderly patients with cancer. , 2001, Critical reviews in oncology/hematology.

[43]  B. Vellas,et al.  Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[44]  M. Extermann,et al.  Management of cancer in the older person: a practical approach. , 2000, The oncologist.

[45]  G. Stanta,et al.  Cancer in the frail patient. A coming epidemic. , 2000, Hematology/oncology clinics of North America.

[46]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[47]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[48]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[49]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[50]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[51]  H. Wildiers,et al.  Performance of two geriatric screening tools in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  H. Cohen,et al.  Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[53]  J. Kazmierska Do we protect or discriminate? Representation of senior adults in clinical trials. , 2012, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[54]  P A Parmelee,et al.  Geriatric Depression Scale , 2002 .

[55]  S. Katz Studies of illness in the aged , 1963 .